Article Details
Retrieved on: 2024-06-02 18:08:44
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights the prominence of biopharma in oncology, emphasizing advances in antibody-drug conjugates (ADCs) like CRB-701 and brentuximab vedotin presented at the ASCO conference. Tags and key concepts align, underscoring innovations in targeted cancer treatments.
Article found on: www.bioworld.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here